Core Insights - The establishment of the Fangchenggang International Medical Open Experimental Zone is aimed at promoting international medical innovation cooperation and building a global health community, as initiated by President Xi Jinping in 2019 [1][2] - The zone has made significant progress in international medical exchanges and cooperation, signing memorandums with foreign parks and hosting numerous international forums [2][3] - The China-ASEAN Regional Pharmaceutical Trading Platform has been launched, facilitating cross-border transactions and supporting Chinese pharmaceutical companies in entering ASEAN markets [4][5] Group 1: International Cooperation and Development - The Fangchenggang International Medical Open Experimental Zone has signed cooperation memorandums with three foreign parks, including Uzbekistan and Pakistan, and has established partnerships for traditional medicine and medical device trade [2] - The zone has hosted over 10 international medical forums, with participation from over 630 officials and experts from 39 countries, resulting in the release of key documents like the "Fangchenggang Declaration" [3] - The zone has actively engaged in international exchanges, sending 209 delegations to 28 countries and collaborating with 11 international sister cities [3] Group 2: Platform and Infrastructure Development - The China-ASEAN Regional Pharmaceutical Trading Platform has been officially launched, featuring 781 types of drugs and 1,652 categories of medical supplies, with participation from 114 Chinese pharmaceutical companies [4] - The platform aims to provide a comprehensive process for cross-border transactions, enhancing the efficiency and safety of medical product exchanges [4] - The establishment of various major platforms, including a national food safety and nutrition innovation platform and a key laboratory for bioactive molecules, has been prioritized to accelerate innovation [5] Group 3: Investment and Financial Initiatives - A QFLP fund with a total scale of 500 million yuan has been established in collaboration with Singapore's UOB, with 200 million yuan already contributed [5] - The Fangchenggang International Medical Open Experimental Zone has seen a significant increase in registered medical device products, from 3 in 2019 to 165 currently, with 37 medical device companies operating in the area [5]

Core Viewpoint - The visit of Turkish academics to Yantai Yuhuangding Hospital marks a significant step in the collaboration between the hospital and Atatürk University, focusing on advancing medical research and technology exchange [1][2]. Group 1: Collaboration and Research Directions - The two institutions identified ten promising research areas for collaboration, including nerve regeneration, allergic rhinitis medication, and mechanisms of traditional Chinese medicine in disease treatment, with five areas already having established cooperation intentions [2][3]. - The collaboration aims to leverage the strengths of both parties, combining Yantai Yuhuangding Hospital's clinical experience with Atatürk University's expertise in molecular biology and nanotechnology, potentially leading to breakthroughs in cancer treatment and neurodegenerative diseases [2][3]. Group 2: Future Plans and Initiatives - Plans for joint international research project applications, co-authoring high-level academic papers, and scholar exchange programs were discussed, with a return visit from Atatürk University planned for November [3]. - The visit included a tour of Yantai Yuhuangding Hospital's key laboratories, which impressed the Turkish experts and reinforced the potential for future collaboration in medical research, technology transfer, and talent development [3].

Core Insights - The "New Silk Road" International Thoracic Surgery Exchange Salon was successfully held in Nanjing, focusing on advancements in thoracic surgery and the importance of international collaboration in the field [1][19]. Group 1: Event Overview - The event was hosted by Jiangsu Provincial People's Hospital and featured seven leading thoracic surgery experts from Germany, including Professor Thorsten Walles and Professor Martin Eichhorn [1]. - The salon included comprehensive discussions on hot topics, treatment advancements, and technological innovations in thoracic surgery [1]. Group 2: Key Presentations - Professor Chen Liang presented on "Conical Resection for Deep Early Lung Cancer," discussing surgical indications, operational key points, and postoperative complication prevention [8]. - Professor Wu Weibing addressed "Neoadjuvant Chemotherapy and Immunotherapy for Locally Advanced Central Lung Cancer," highlighting revolutionary opportunities for individualized treatment strategies [8]. - Professor Zhu Quan discussed the "Fissure-type Lung Segment Resection," detailing its technical points and clinical application value [8]. Group 3: International Collaboration - The event emphasized the importance of international collaboration in thoracic surgery, aiming to build a more open and inclusive global network [19]. - The German delegation shared insights on the "Magdeburg Model," showcasing how to establish an efficient thoracic surgery diagnosis and treatment system between hospitals [10]. - The exchange aimed to enhance cooperation in talent cultivation, technological innovation, and clinical research to address global challenges in thoracic surgery [19]. Group 4: Hands-on Learning - The event included live demonstrations of advanced surgical techniques such as three-dimensional reconstruction navigation surgery and single-port thoracoscopic lung segment resection [12]. - The German experts showed great interest in Jiangsu Provincial People's Hospital's precise lung segment and sub-segment resection surgical system [12]. Group 5: Closing Ceremony - A certificate awarding ceremony was held, recognizing the contributions of participating experts [15][17]. - The event concluded with the presentation of a book on innovative thoracic surgery techniques to the German physicians, marking a successful academic exchange [17].